ESC Premium Access

Catheter ablation is associated with reduced all-cause mortality in a real-world cohort of patients with atrial fibrillation and heart failure

Congress Session

About the speaker

Assistant Professor Michelle Samuel

Montreal Heart Institute, Montreal (Canada)
1 presentation
0 follower

14 more presentations in this session

Clinical predictors for the improvement of left ventricular ejection fraction and prognosis after catheter ablation of atrial fibrillation in patients with systolic dysfunction

Speaker: Doctor K. Nagaoka (Kurume, JP)

Thumbnail

Risk factors for the occurrence of stroke after atrial fibrillation ablation

Speaker: Professor S. Han (Anyang-Si, Gyeonggi-Do, KR)

Thumbnail

The risk of dementia and catheter ablation for atrial fibrillation: a nationwide cohort study

Speaker: Assistant Professor P. Yang (Seongnam, KR)

Thumbnail

Impact of atrial fibrillation ablation procedural volume on complication and recurrence rate across european centers. An ESC EORP registry: atrial fibrillation long-term.

Speaker: Doctor E. Pagourelias (Thessaloniki, GR)

Thumbnail

Catheter ablation outcome and heart failure hospitalization in atrial fibrillation patients: insights from the Kansai plus atrial fibrillation (KPAF) registry

Speaker: Doctor N. Tanaka (Osaka, JP)

Thumbnail

Access the full session

Poster Session 1 - Atrial fibrillation ablation and outcomes

Speakers: Assistant Professor M. Samuel, Doctor K. Nagaoka, Professor S. Han, Assistant Professor P. Yang, Doctor E. Pagourelias...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk